Guardant Health Inc (NAS:GH)
$ 29.54 0 (0%) Market Cap: 3.61 Bil Enterprise Value: 3.83 Bil PE Ratio: 0 PB Ratio: 52.66 GF Score: 70/100

Guardant Health Inc at Piper Sandler Healthcare Conference Transcript

Nov 28, 2023 / 02:30PM GMT
Release Date Price: $24.79 (+1.60%)
David Michael Westenberg
Piper Sandler & Co., Research Division - MD & Senior Research Analyst

Thank you, everybody, for joining us. Today, we have Guardant Health, AmirAli, the Co-CEO; and Mike Bell, the CFO. Guardant Health probably doesn't need too much of an introduction, so maybe let's just dive into a little bit more about some of your innovation here.

Questions & Answers

David Michael Westenberg
Piper Sandler & Co., Research Division - MD & Senior Research Analyst

Can you talk about smart liquid biopsy, AI and the constant improvement of your assays that you're doing, starting from Guardant360, through the portfolio, the constant innovation and compound innovation, as you like to call it?

AmirAli Talasaz
Guardant Health, Inc. - Co-CEO & Director

Yes, sure. Hello, everybody. Good to be here. So as the tagline of the company says, conquer cancer with data. We are a company that has been focused on capturing data, high-quality data that would help with this mission of adding

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot